NCT06262854View on ClinicalTrials.gov

Efficacy and Safety of Stimulan® for the Treatment of Diabetic Foot Osteomyelitis. The BIG D-FOOT Study

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

May 31, 2025

Conditions

Diabete MellitusFoot UlcerOsteomyelitis - FootSurgical Procedure, Unspecified

Interventions

DEVICE

Calcium-sulphate granules with tobramicina+vancomicina

Local calcium-sulphate antibiotics deliver for the treatment of diabetic foot osteomyelitis

All Listed Sponsors

lead

Azienda Ospedaliero-Universitaria Careggi

OTHER

NCT06262854 - Efficacy and Safety of Stimulan® for the Treatment of Diabetic Foot Osteomyelitis. The BIG D-FOOT Study | Biotech Hunter | Biotech Hunter